Quarterly report pursuant to Section 13 or 15(d)

RELATED PARTY TRANSACTIONS (Details Narrative)

v3.21.2
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Feb. 16, 2021
Apr. 30, 2019
Jul. 28, 2016
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Feb. 26, 2020
Jan. 22, 2019
Jun. 13, 2018
Related party payables         $ 925,878   $ 686,068      
Common stock shares issued, descripiton         the other one was with the J and R Galligan Revocable Trust, managed by Mr. Joseph Galligan, a holder of between 5% and 10% of the Company's shares of common stock          
Proceeds from royalty   $ 6,000,000                
Proceeds from related party         $ 500,000 $ 0        
Common stock par value         $ 0.001   $ 0.001      
Common stock shares issued         6,642,279   5,463,444      
March, 1 2019 [Member] | Director Agreement [Member]                    
Common stock issuable value         $ 5,000          
Compensation for services         $ 15,000          
Common stock shares issued to related party       35,165 25,687          
Common stock value issued to related party       $ 25,000 $ 77,500 75,000        
Joseph Galligan [Member]                    
Monthly remuneration                 $ 6,250  
Consulting fees       $ 4,032   $ 4,032        
Base salary               $ 75,000    
Joseph Galligan [Member] | Maximum [Member]                    
Ownership percentage         10          
Two Subscription And Royalty Agreements [Member]                    
Unpaid balance         $ 210   $ 210      
Lucido Subscription Agreement [Member]                    
Purchase price $ 2.00                  
Subscription aggregate amount receivable $ 1,125,000                  
Common stock par value $ 0.001                  
Common stock shares issued 562,500                  
Alpine Creek [Member]                    
Proceeds from related party         1,125,000          
Remaining consideration amount         $ 1,531,926          
Payment description         In the event that the Company has not paid Alpine Creek $1,215,000 within 24 months of the Effective Date, then the Company shall continue to pay Alpine Creek fifty percent (50%) for each Treatment following the Effective Date until the Company has paid Alpine Creek an aggregate of $1,620,000, with the exception of treatments conducted in certain territories.          
Due royalty         $ 91   $ 91      
Amount pay for each treatment sold         $ 100          
Distribution description         the Company shall pay 2.5% of the Company's gross profit for implant distribution not to exceed $100 per sale. On or about January 1, 2021, Mr. Joseph Galligan, a holder of between 5% and 10% of the Company's shares of common stock and, as of February 16, 2021, a member of the Board, acquired from Alpine Creek the rights to the subscription and royalty agreement by and between the Company and Alpine Creek.          
Mr. Brady Granier [Member]                    
Base salary               215,000    
Ms. Lourdes Felix [Member] | January 1, 2020 [Member]                    
Base salary         $ 190,000          
Mr. Tom Welch, VP of Operations [Member]                    
Base salary         150,000     $ 165,000    
Monthly remuneration                   $ 12,500
Soupface LLC [Member]                    
Base salary         190,000          
Monthly remuneration                   15,833
FFE [Member]                    
Base salary         $ 175,000          
Monthly remuneration                   $ 14,583
Board of Directors [Member]                    
Common stock shares issued       35,165 25,687 35,165        
Ownership percentage     24.2              
Ownership percentage held by Company     75.8